The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Open accessAbstract
Soft tissue sarcomas (STS) are rare malignancies of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of patients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Soft Tissue Sarcoma provide recommendations for the diagnosis, evaluation, and treatment of extremity/superficial trunk/head and neck STS, as well as retroperitoneal/intra-abdominal STS, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guidelines discusses general principles for the diagnosis and treatment of retroperitoneal/intra-abdominal STS, outlines treatment recommendations, and reviews the evidence to support the guidelines recommendations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21708 · Cited by 17,196
Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
Drilon, A., Laetsch, T. W., Kummar, S., DuBois, S. G., Lassen, U. N., Demetri, G. D., Nathenson, M., Doebele, R. C., Farago, A. F., Pappo, A. S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714448 · Cited by 2,824
Self-citationvan der Graaf, W. T., Blay, J.-Y., Chawla, S. P., Kim, D.-W., Bui-Nguyen, B., Casali, P. G., Schöffski, P., Aglietta, M., Staddon, A. P., Beppu, Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60651-5 · Cited by 2,102
Doebele, R. C., Drilon, A., Paz-Ares, L., Siena, S., Shaw, A. T., Farago, A. F., Blakely, C. M., Seto, T., Cho, B. C., Tosi, D., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30691-6 · Cited by 1,790
Judson, I., Verweij, J., Gelderblom, H., Hartmann, J. T., Schöffski, P., Blay, J.-Y., Kerst, J. M., Sufliarsky, J., Whelan, J., Hohenberger, P., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70063-4 · Cited by 1,183
Pervaiz, N., Colterjohn, N., Farrokhyar, F., Tozer, R., Figueredo, A., & Ghert, M. (2008) · Cancer · doi:10.1002/cncr.23592 · Cited by 987
Demetri, G. D., von Mehren, M., Jones, R. L., Hensley, M. L., Schuetze, S. M., Staddon, A., Milhem, M., Elias, A., Ganjoo, K., Tawbi, H., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.4734 · Cited by 841
Self-citationSchöffski, P., Chawla, S., Maki, R. G., Italiano, A., Gelderblom, H., Choy, E., Grignani, G., Camargo, V., Bauer, S., Rha, S. Y., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01283-0 · Cited by 778
Self-citationMaki, R. G., Wathen, J. K., Patel, S. R., Priebat, D. A., Okuno, S. H., Samuels, B., Fanucchi, M., Harmon, D. C., Schuetze, S. M., Reinke, D., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.4117 · Cited by 742
Self-citationFrustaci, S., Gherlinzoni, F., De Paoli, A., Bonetti, M., Azzarelli, A., Comandone, A., Olmi, P., Buonadonna, A., Pignatti, G., Barbieri, E., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1238 · Cited by 712
Sleijfer, S., Ray-Coquard, I., Papai, Z., Le Cesne, A., Scurr, M., Schöffski, P., Collin, F., Pandite, L., Marreaud, S., De Brauwer, A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.3223 · Cited by 679
Bonvalot, S., Rivoire, M., Castaing, M., Stoeckle, E., Le Cesne, A., Blay, J. Y., & Laplanche, A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0802 · Cited by 644
Demetri, G. D., Chawla, S. P., von Mehren, M., Ritch, P., Baker, L. H., Blay, J. Y., Hande, K. R., Keohan, M. L., Samuels, B. L., Schuetze, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.0088 · Cited by 538
Self-citationSeddon, B., Strauss, S. J., Whelan, J., Leahy, M., Woll, P. J., Cowie, F., Rothermundt, C., Wood, Z., Benson, C., Ali, N., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30622-8 · Cited by 528
Santoro, A., Tursz, T., Mouridsen, H., Verweij, J., Steward, W., Somers, R., Buesa, J., Casali, P., Spooner, D., & Rankin, E. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1537 · Cited by 526
Edmonson, J. H., Ryan, L. M., Blum, R. H., Brooks, J. S., Shiraki, M., Frytak, S., & Parkinson, D. R. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.7.1269 · Cited by 516
Gronchi, A., Ferrari, S., Quagliuolo, V., Broto, J. M., Pousa, A. L., Grignani, G., Basso, U., Blay, J.-Y., Tendero, O., Beveridge, R. D., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30334-0 · Cited by 496
Bonvalot, S., Gronchi, A., Le Péchoux, C., Swallow, C. J., Strauss, D., Meeus, P., van Coevorden, F., Stoldt, S., Stoeckle, E., Rutkowski, P., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30446-0 · Cited by 493
Antman, K. H., Crowley, J. J., Balcerzak, S. P., Rivkin, S. E., Weiss, G. R., ELIAS, A. D., Natale, R. B., Cooper, R. M., Barlogie, B., & Trump, D. L. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.7.1276 · Cited by 478
Le Cesne, A., Blay, J. Y., Judson, I., Van Oosterom, A., Verweij, J., Radford, J., Lorigan, P., Rodenhuis, S., Ray-Coquard, I., Bonvalot, S., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.180 · Cited by 421
Intraoperative Radiotherapy in Retroperitoneal Sarcomas
Sindelar, W. F. (1993) · Archives of Surgery · doi:10.1001/archsurg.1993.01420160040005 · Cited by 393
Judson, I., Radford, J. A., Harris, M., Blay, J.-Y., van Hoesel, Q., le Cesne, A., van Oosterom, A. T., Clemons, M. J., Kamby, C., Hermans, C., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00050-8 · Cited by 392
A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma
Gortzak, E., Azzarelli, A., Buesa, J., Bramwell, V. H. C., van Coevorden, F., van Geel, A. N., Ezzat, A., Santoro, A., Oosterhuis, J. W., van Glabbeke, M., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00083-1 · Cited by 379
Heslin, M. J., Lewis, J. J., Nadler, E., Newman, E., Woodruff, J. M., Casper, E. S., Leung, D. H. Y., & Brennan, M. F. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.8.2832 · Cited by 318
Phase II Study of Ecteinascidin-743 in Advanced Pretreated Soft Tissue Sarcoma Patients
Yovine, A., Riofrio, M., Blay, J. Y., Brain, E., Alexandre, J., Kahatt, C., Taamma, A., Jimeno, J., Martin, C., Salhi, Y., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.210 · Cited by 310
García-del-Muro, X., López-Pousa, A., Maurel, J., Martín, J., Martínez-Trufero, J., Casado, A., Gómez-España, A., Fra, J., Cruz, J., Poveda, A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.6107 · Cited by 307
Mir, O., Brodowicz, T., Italiano, A., Wallet, J., Blay, J.-Y., Bertucci, F., Chevreau, C., Piperno-Neumann, S., Bompas, E., Salas, S., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30507-1 · Cited by 280
Kraybill, W. G., Harris, J., Spiro, I. J., Ettinger, D. S., DeLaney, T. F., Blum, R. H., Lucas, D. R., Harmon, D. C., Letson, G. D., & Eisenberg, B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.5577 · Cited by 278
ELIAS, A. D., RYAN, L. M., Sulkes, A., Collins, J. M., Aisner, J., & Antman, K. H. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.9.1208 · Cited by 275
Radiation-Associated Sarcoma of Bone and Soft Tissue
Brady, M. S. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420120013002 · Cited by 258
Pawlik, T. M., Pisters, P. W. T., Mikula, L., Feig, B. W., Hunt, K. K., Cormier, J. N., Ballo, M. T., Catton, C., Jones, J., O'Sullivan, B. P., et al. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.05.035 · Cited by 256
Lorigan, P., Verweij, J., Papai, Z., Rodenhuis, S., Le Cesne, A., Leahy, M. G., Radford, J. A., Van Glabbeke, M. M., Kirkpatrick, A., Hogendoorn, P. C. W., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7717 · Cited by 256
Bramwell, V, Rouesse, J., Steward, W., Santoro, A., Schraffordt-Koops, H., Buesa, J., Ruka, W., Priario, J., Wagener, T., & Burgers, M. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.6.1137 · Cited by 244
Schöffski, P., Ray-Coquard, I. L., Cioffi, A., Bui, N. B., Bauer, S., Hartmann, J. T., Krarup-Hansen, A., Grünwald, V., Sciot, R., Dumez, H., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70230-3 · Cited by 244
The epidemiology of soft tissue sarcoma.
Zahm, S. H., & Fraumeni, J. F. (1997) · PubMed · Cited by 232
Gieschen, H. L., Spiro, I. J., Suit, H. D., Ott, M. J., Rattner, D. W., Ancukiewicz, M., & Willett, C. G. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01589-3 · Cited by 227
Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma
Grobmyer, S. R., Maki, R. G., Demetri, G. D., Mazumdar, M., Riedel, E., Brennan, M. F., & Singer, S. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh431 · Cited by 224
Kawai, A., Araki, N., Sugiura, H., Ueda, T., Yonemoto, T., Takahashi, M., Morioka, H., Hiraga, H., Hiruma, T., Kunisada, T., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70098-7 · Cited by 217
Savina, M., Le Cesne, A., Blay, J.-Y., Ray-Coquard, I., Mir, O., Toulmonde, M., Cousin, S., Terrier, P., Ranchere-Vince, D., Meeus, P., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0831-7 · Cited by 208
Toulmonde, M., Pulido, M., Ray-Coquard, I., Andre, T., Isambert, N., Chevreau, C., Penel, N., Bompas, E., Saada, E., Bertucci, F., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30276-1 · Cited by 206
Garcia-Carbonero, R., Supko, J. G., Maki, R. G., Manola, J., Ryan, D. P., Harmon, D., Puchalski, T. A., Goss, G., Seiden, M. V., Waxman, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.028 · Cited by 192
High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas
Alektiar, K. M., Hu, K., Anderson, L., Brennan, M. F., & Harrison, L. B. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00546-5 · Cited by 190
Docetaxel and gemcitabine combination in 133 advanced soft‐tissue sarcomas: A retrospective analysis
Bay, J., Ray‐Coquard, I., Fayette, J., Leyvraz, S., Cherix, S., Piperno‐Neumann, S., Chevreau, C., Isambert, N., Brain, E., Emile, G., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21867 · Cited by 189
Florou, V., Rosenberg, A. E., Wieder, E., Komanduri, K. V., Kolonias, D., Uduman, M., Castle, J. C., Buell, J. S., Trent, J. C., & Wilky, B. A. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0689-7 · Cited by 185
Petersen, I. A., Haddock, M. G., Donohue, J. H., Nagorney, D. M., Grill, J. P., Sargent, D. J., & Gunderson, L. L. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)02595-0 · Cited by 183
Self-citationBramwell, V., Anderson, D., Charette, M., & Sarcoma Disease Site Group (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003293 · Cited by 172
Cormier, J. N., Huang, X., Xing, Y., Thall, P. F., Wang, X., Benjamin, R. S., Pollock, R. E., Antonescu, C. R., Maki, R. G., Brennan, M. F., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.057 · Cited by 163
Mouridsen, H. T., Bastholt, L., Somers, R., Santoro, A., Bramwell, V. H. C., Mulder, J. H., van Oosterom, A. T., Buesa, J., Pinedo, H. M., Thomas, D., et al. (1987) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(87)90089-7 · Cited by 154
Pisters, P. W. T., Ballo, M. T., Fenstermacher, M. J., Feig, B. W., Hunt, K. K., Raymond, K. A., Burgess, M. A., Zagars, G. K., Pollock, R. E., Benjamin, R. S., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.143 · Cited by 152
Albertsmeier, M., Rauch, A., Roeder, F., Hasenhütl, S. M., Pratschke, S., Kirschneck, M., Gronchi, A., Jebsen, N. L., Cassier, P. A., Sargos, P., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6081-2 · Cited by 146
Retroperitoneal sarcomas: Combined-modality treatment approaches
Raut, C. P., & Pisters, P. W. T. (2006) · Journal of Surgical Oncology · doi:10.1002/jso.20543 · Cited by 142
Tzeng, C.-W. D., Fiveash, J. B., Popple, R. A., Arnoletti, J. P., Russo, S. M., Urist, M. M., Bland, K. I., & Heslin, M. J. (2006) · Cancer · doi:10.1002/cncr.22005 · Cited by 139
Young, R., Natukunda, A., Litière, S., Woll, P. J., Wardelmann, E., & van der Graaf, W. T. A. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.10.004 · Cited by 137
Trent, J. C., Beach, J. L., Burgess, M. A., Papadopolous, N., Chen, L. L., Benjamin, R. S., & PATEL, S. R. (2003) · Cancer · doi:10.1002/cncr.11875 · Cited by 129
Blay, J., Leahy, M. G., Nguyen, B. B., PATEL, S. R., Hohenberger, P., Santoro, A., Staddon, A. P., Penel, N., Piperno-Neumann, S., Hendifar, A. E., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.01.012 · Cited by 123
Baldini, E. H., Wang, D., Haas, R. L., Catton, C., Indelicato, D. J., Kirsch, D. G., Roberge, D., Salerno, K. E., Deville, C., Guadagnolo, B. A., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.02.013 · Cited by 119
Self-citationAdjuvant Radiation Therapy for Resectable Retroperitoneal Soft Tissue Sarcoma
Zlotecki, R. A., Katz, T. S., Morris, C. G., Lind, D. S., & Hochwald, S. N. (2005) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000158441.96455.31 · Cited by 116
Yoon, S. S., Chen, Y., Kirsch, D. G., Maduekwe, U. N., Rosenberg, A. E., Nielsen, G. P., Sahani, D. V., Choy, E., Harmon, D. C., & DeLaney, T. F. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0935-1 · Cited by 103
Self-citationReichardt, P., Tilgner, J., Hohenberger, P., & Dörken, B. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1438 · Cited by 99
Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma
Laverdière, C., Kolb, E. A., Supko, J. G., Gorlick, R. G., Meyers, P. A., Maki, R. G., Wexler, L. H., Demetri, G. D., Healey, J. H., Huvos, A. G., et al. (2003) · Cancer · doi:10.1002/cncr.11563 · Cited by 98
Penel, N., Grosjean, J., Robin, Y. M., Vanseymortier, L., Clisant, S., & Adenis, A. (2008) · Sarcoma · doi:10.1155/2008/459386 · Cited by 96
A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma
Talbot, S. M., Keohan, M. L., Hesdorffer, M. E., Orrico, R., Bagiella, E., Troxel, A. B., & Taub, R. N. (2003) · Cancer · doi:10.1002/cncr.11730 · Cited by 95
del Muro, X. G., Pousa, A. L., Martín‐Broto, J., Buesa, J., Martínez‐Trufero, J., Casado, A., Poveda, A. M., Cruz, J., Bover, I., & Maurel, J. (2005) · Cancer · doi:10.1002/cncr.21384 · Cited by 94
Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma
Krempien, R. C., Roeder, F., Oertel, S., Weitz, J., Hensley, F. W., Timke, C., Funk, A., Lindel, K., Harms, W., Büchler, M. W., et al. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.01.028 · Cited by 92
Coens, C., van der Graaf, W. T. A., Blay, J., Chawla, S. P., Judson, I. R., Sanfilippo, R. G., Manson, S. C., Hodge, R. A., Marreaud, S. I., Prins, J. B., et al. (2015) · Cancer · doi:10.1002/cncr.29426 · Cited by 89
Grünwald, V., Karch, A., Schuler, M. K., Schöffski, P., Kopp, H., Bauer, S., Kasper, B., Lindner, L. H., Chemnitz, J., Crysandt, M. M., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00714 · Cited by 86
Windham, T. C., & Pisters, P. W. T. (2005) · Cancer Control · doi:10.1177/107327480501200105 · Cited by 86
Roeder, F., Schulz–Ertner, D., Nikoghosyan, A. V., Huber, P., Edler, L., Habl, G., Krempien, R. C., Oertel, S., Saleh-Ebrahimi, L., Hensley, F. W., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-287 · Cited by 84
Dileo, P., Morgan, J. A., Zahrieh, D., Desai, J., Salesi, J. M., Harmon, D. C., Quigley, M. T., Polson, K., Demetri, G. D., & George, S. (2007) · Cancer · doi:10.1002/cncr.22609 · Cited by 80
Martín‐Broto, J., Pousa, A. L., Peñas, R. D. L., del Muro, X. G., Gutierrez, A. M., Martínez‐Trufero, J., Cruz, J., Alvarez, R. M., Cubedo, R., Redondo, A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.3329 · Cited by 74
Swanson, E. L., Indelicato, D. J., Louis, D. A., Flampouri, S., Li, Z., Morris, C. G., Paryani, N. N., & Slopsema, R. L. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.10.014 · Cited by 71
Kuttesch, J. F., Krailo, M., Madden, T. L., Johansen, M. J., & Bleyer, A. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22133 · Cited by 54
Kim, B., Chen, Y.-L. E., Kirsch, D. G., Goldberg, S. I., Kobayashi, W. K., Kung, J., Wolfgang, J. A., Doppke, K. P., Rosenberg, A. E., Nielsen, G. P., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.06.086 · Cited by 49
Current concepts and future perspectives in retroperitoneal soft-tissue sarcoma management
Thomas, D. M., O’Sullivan, B., & Gronchi, A. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.77 · Cited by 46
Bobin, J. Y., Al-Lawati, T. T., Granero, L. E., Adham, M., Romestaing, P., Chapet, O., Issac, S. E., & Gérard, J. P. (2003) · European Journal of Surgical Oncology · doi:10.1016/s0748-7983(03)00139-2 · Cited by 46
Burgess, M. A., Bolejack, V., Tine, B. A. V., Schuetze, S. M., Hu, J. S., D’Angelo, S. P., Attia, S., Priebat, D. A., Okuno, S. H., Riedel, R. F., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.15_suppl.11008 · Cited by 40
Self-citationVoss, R. K., Chiang, Y., Torres, K. E., Guadagnolo, B. A., Mann, G. N., Feig, B. W., Cormier, J. N., & Roland, C. L. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6015-z · Cited by 34
An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma
Agulnik, M., Schulte, B. C., Robinson, S. I., Hirbe, A. C., Kozak, K. R., Chawla, S. P., Attia, S., RADEMAKER, A. W., Zhang, H., Abbinanti, S. E., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.06.027 · Cited by 29
Self-citationMusat, E., Kantor, G., Caron, J., Lagarde, P., Laharie, H., Stoeckle, E., Angles, J., Gilbeau, L., & Bui, B. (2004) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2004.05.001 · Cited by 26
Baldini, E. H., Bosch, W. R., Kane, J. M., Abrams, R. A., Salerno, K. E., Deville, C., Raut, C. P., Petersen, I. A., Chen, Y., Mullen, J. T., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4633-x · Cited by 24
Self-citationRole of chemotherapy in patients with soft tissue sarcomas
Maki, R. G. (2004) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.4.2.229 · Cited by 24
Somaiah, N., Tine, B. A. V., Wahlquist, A. E., Milhem, M. M., Hill, E. G., Garrett-Mayer, E. S., Armeson, K. E., Schuetze, S. M., Meyer, C. F., Reuben, D. Y., et al. (2020) · Cancer · doi:10.1002/cncr.33216 · Cited by 20
Self-citationYoon, S. S., Chen, Y., Kambadakone, A. R., Schmidt, B. H., & DeLaney, T. F. (2012) · Practical Radiation Oncology · doi:10.1016/j.prro.2012.06.008 · Cited by 18
Cited by
Massard, C., Gordon, M. S., Sharma, S., Rafii, S., Wainberg, Z. A., Luke, J., Curiel, T. J., Colon-Otero, G., Hamid, O., Sanborn, R. E., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.9761 · Cited by 840
Schöffski, P., Chawla, S., Maki, R. G., Italiano, A., Gelderblom, H., Choy, E., Grignani, G., Camargo, V., Bauer, S., Rha, S. Y., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01283-0 · Cited by 778
Self-citationAnlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development
Shen, G., Zheng, F., Ren, D., Du, F., Dong, Q., Wang, Z., Zhao, F., Ahmad, R., & Zhao, J. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0664-7 · Cited by 658
Thuss-Patience, P. C., Shah, M. A., Ohtsu, A., Van Cutsem, E., Ajani, J. A., Castro, H., Mansoor, W., Chung, H. C., Bodoky, G., Shitara, K., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30111-0 · Cited by 547
Bonvalot, S., Rutkowski, P. L., Thariat, J., Carrère, S., Ducassou, A., Sunyach, M.-P., Agoston, P., Hong, A., Mervoyer, A., Rastrelli, M., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30326-2 · Cited by 536
Metadata
- Authors
- von Mehren, M., Kane, J. M., Agulnik, M., Bui, M. M., Carr-Ascher, J., Choy, E., Connelly, M., Dry, S., Ganjoo, K. N., Gonzalez, R. J., Holder, A., Homsi, J., Keedy, V., Kelly, C. M., Kim, E., Liebner, D., McCarter, M., McGarry, S. V., Mesko, N. W., Meyer, C., Pappo, A. S., Parkes, A. M., Petersen, I. A., Pollack, S. M., Poppe, M., Riedel, R. F., Schuetze, S., Shabason, J., Sicklick, J. K., Spraker, M. B., Zimel, M., Hang, L. E., Sundar, H., & Bergman, M. A.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2022-07
- Volume
- 20
- Issue
- 7
- Pages
- 815-833
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W4285097283
- Cited by
- 1,182
- References
- 83
- FWCI
- 46.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.